Abstract. Mutations in the MECP2 gene are found in a large proportion of girls with Rett Syndrome. Despite extensive research, the principal role of MeCP2 protein remains elusive. Is MeCP2 a regulator of genes, acting in concert with co-activators and co-repressors, predominantly as an activator of target genes or is it a methyl CpG binding protein acting globally to change the chromatin state and to supress transcription from repeat elements? If MeCP2 has no specific targets in the genome, what causes the differential expression of specific genes in the Mecp2 knockout mouse brain? We discuss the discrepancies in current data and propose a hypothesis to reconcile some differences in the two viewpoints. Since transcripts from repeat elements contribute to piRNA biogenesis, we propose that piRNA levels may be higher in the absence of MeCP2 and that increased piRNA levels may contribute to the mis-regulation of some genes seen in the Mecp2 knockout mouse brain. We provide preliminary data showing an increase in piRNAs in the Mecp2 knockout mouse cerebellum. Our investigation suggests that global piRNA levels may be elevated in the Mecp2 knockout mouse cerebellum and strongly supports further investigation of piRNAs in Rett syndrome.
Rett Syndrome (RTT), a severe neurodevelopmental disorder, leads to intellectual disability in girls. After a normal prenatal and postnatal period, patients usually present with developmental delay between 6 and 18 months of age, followed by the development of stereotypic hand movements and loss of acquired skills including voluntary hand use, language and communication. This regression is characteristic of Rett Syndrome which, in 97% of clinically diagnosed classic cases and 70% of atypical cases, is caused by mutations in the methyl CpG binding protein 2 gene, (MECP2) [1] . In some patients with atypical Rett Syndrome, where some but not all clinical features are seen, mutations in CDKL5 [2] or FOXG1 [3] are found, albeit infrequently. Diagnosis of Rett Syndrome is based on clinical criteria [4] and confirmed upon detection of a mutation in MECP2, CDKL5 or FOXG1. However, in approximately 20% of girls clinically diagnosed with classic or atypical Rett syndrome, mutations cannot be detected in either of these genes.
MECP2 gene undergoes X chromosome inactivation (XCI) [5] , which means that in any cell with two X chromosomes, RNA transcripts arise only from the MECP2 gene on the active X chromosome. This is because the MECP2 gene on the inactive X chromosome has been silenced. Chaumeil et al. demonstrated, through in-situ hybridization in mouse ES cells, that the Mecp2 gene moves inside the silencing compartment of Xist on the 4th day after differentiation [6] . Although some genes are known to escape X inactivation in humans and mouse [7] [8] [9] [10] , Carrel et al. showed using rodent/human somatic hybrid cell lines that in humans MECP2 transcripts are not expressed from the inactive X chromosome [7] . Due to the random nature of X inactivation, part of the clinical variability in RTT is attributed to the differences in the X inactivation status of patients [11] [12] [13] , however more recent data suggest X inactivation status may not adequately explain the phenotypic variations [14] .
MECP2 gene is composed of 4 exons and generates two transcripts which encode two nearly identical protein isoforms [15, 16] . MeCP2 e1, which commences translation from exon 1, is encoded from a transcript encompassing exons 1, 3 and 4; and MeCP2 e2, which starts translation from the end of exon 2, is generated from a transcript arising from exons 1, 2, 3 and 4, where exon 1 and most of exon 2 form the 5'UTR [15, 16] . Although MECP2 is expressed in all tissues, semiquantitative PCR analysis has shown that Mecp2 e1 may have a higher expression level over Mecp2 e2 in the brain [16] . Mutations in exons 3 and 4 affect both protein isoforms and are frequently found in Rett patients. Mutations in exon 1 can cause Rett syndrome despite the fact that mutations in exon 1 do not affect the coding region of the MeCP2 e2 protein. Interestingly, mutations in exon 2 of the gene, which have the potential to affect the MeCP2 e2 isoform alone, have so far not been found in patients. While earlier work on an Australian patient with a recurrent deletion in exon 1 of MECP2 gene demonstrated the absence of MeCP2 e2 protein correlated with X inactivation status, suggesting translational interference from the mutation [17] , a recent publication found no evidence of loss of MeCP2 e2 protein in a Canadian patient with a similar mutation indicating that some patients may present with clinical features of Rett syndrome even in the presence of a fully functional MeCP2 e2 isoform [18] . Interestingly, this data also suggests that despite high sequence similarities there is no functional redundancy between the two protein isoforms.
Due to its property to bind methylated DNA with high affinity and its association with repressor complexes consisting of HDAC1/2 and Sin3A, MeCP2 was believed to function as a transcriptional repressor [19, 20] . The MeCP2-DNA interaction was shown to result in chromatin compaction, which is also correlated with silencing of chromatin [21] . Subsequent studies revealed that MeCP2 had binding affinity to methylated DNA as well as non-methylated DNA [22] . Absence of MeCP2 in mouse brains also results in an increase in H3Ac levels, suggesting a role for MeCP2 in chromatin modification [23, 24] . Recent data suggest that MeCP2 protein may be a regulator of transcription, acting in concert with activators as well as repressors to regulate gene expression. Yasui et al. first reported that promoter occupancy by MeCP2 may not result in gene silencing [25] . Using a custom tiling array of selected chromosomal regions totalling 26.3 Mb, they performed ChIP-chip analysis on SH-SY5Y cells with antibodies against MeCP2 and RNA polymerase II. The data revealed co-occupancy of MeCP2 and RNA Polymerase II at selected promoters suggesting that MeCP2 binding may not be correlated to gene repression [25] . Using ChIP-chip assays for 24,275 promoters, they demonstrated that only 2600-4300 promoters were occupied by MeCP2, of which 1534 promoters showed strongest enrichment. Comparison with gene expression arrays in the same cell lines revealed that almost 63% of the "strongest" promoters were expressed in SH-SY5Y cells. Subsequent MeDIP-ChIP analysis revealed that just 2.2% of methylated promoters were occupied by MeCP2 [25] . These data were supported in part by Chahrour et al. who used microarrays to determine differentially expressed genes in the hypothalamus of 6 week old Mecp2 knockout (KO) mouse and in the hypothalamus of a mouse model that overexpressed Mecp2 under its endogenous promoter (Tg) [26] . Combining their data from the KO and Tg models, they identified 2561 genes as direct targets of MeCP2, of which ∼85% were activated by MeCP2 and ∼ 15% were repressed by MeCP2 [26] . Using mass spectrometry on proteins co-immunoprecipitated with an anti-MeCP2 antibody, they identified CREB1 as a co-activator associated with MeCP2 and demonstrated co-occupancy of the two proteins at an activated target Sst [26] . Together, these data established MeCP2 as an activator of transcription [25, 26] . Thus transcriptional mis-regulation is believed to underlie the phenotype seen in patients with mutations in the MECP2 gene. In view of the fact that FOXG1 is a member of the forkhead family of transcription regulators,it is likely that in patients carrying mutations in FOXG1, mis-regulation of genes may contribute to the phenotypic features. The molecular pathology leading to the clinical phenotype of Rett Syndrome in mutation negative patients remains unknown. While much has been reported on the misregulation of specific genes after MeCP2 knockdown (KD) or KO, such studies have not yet been reported for FOXG1. Other studies reveal subtle changes in the expression levels of specific genes after MeCP2 KD or in the Mecp2 KO mouse brain rather than genome wide transcriptional mis-regulation [27] [28] [29] .
However, a recent report suggests that the absence of a functional MeCP2 may result widespread misregulation of repeat elements. Skene et al. investigated MeCP2 binding on selected loci in the mature mouse brain using ChIP-qPCR and demonstrated that MeCP2 was enriched all across the loci, but the enrichment was reduced over CpG islands, which are generally methylation free [24] . With bisulfite modification and sequencing of selected loci they demonstrated the recovery of predominantly methylated chromatin from the MeCP2 ChIP, re-emphasizing the role of MeCP2 as a methyl CpG binding protein [24] . Based on their investigation of the histone acetylation status by Western blotting and H3Ac ChIP-qPCR at 100 loci, they concluded that the association of MeCP2 with chromatin causes a genome-wide decrease in histone acetylation [24] . To investigate the binding sites of MeCP2 genome wide, Skene et al. performed MeCP2-ChIPsequencing on the whole brain. Despite deep sequencing, they did not find peaks of MeCP2 occupancy, but found reads which coincided with methylated regions of the genome. Since they did not uncover specific binding targets of MeCP2 in the genome, they hypothesized that MeCP2 may act at a global level, most likely to supress transcription from the repeat regions of the genome [24] . Using qPCR, they demonstrated a 1.6 fold increase in transcripts arising from repeat sequences such as LINE-1, intra-cisternal A particles (IAPs) and major satellite DNA in the nuclear fraction of the Mecp2 KO mouse brain. Based on their data they proposed that MeCP2 functions to repress spurious transcription of repeat elements [24] rather than to activate specific gene targets. An earlier investigation into the association between MeCP2 and LINE-1 and Alus had revealed that MeCP2 repressed LINE-1 expression and transposition, but activated Alu expression [30] . The role of MeCP2 in repressing transcription and transposition of LINE-1 elements was also corroborated by independent studies from the Gage Lab that showed that LINE-1 is over expressed in neuron progenitor cells after KD of MeCP2 and in neurons derived from Rett patients [31] . The data from Yasui et al. suggests that MeCP2 displays limited binding to methylated sites [25] and from Chahrour et al. proposes that MeCP2 acts as a transcriptional activator of specific targets [26] . In contrast, the data from Skene et al. suggests that MeCP2 binds methylated DNA, is a modulator of global chromatin state and may not have specific gene targets [24] . We note that some of these studies were conducted using microarrays or custom tiling arrays, which are generally limited to gene specific probes and exclude repeat sequences. Despite contradictory inferences on MeCP2 function, the fact remains that specific genes are mis-expressed and repeat elements are over-expressed in Mecp2 KO mice. To reconcile the two opposing views, an alternative model would suggest that the key role of MeCP2 is to silence LINEs and similar repeat elements globally and that the observed mis-expression of genes is a downstream consequence of mis-expressed repeat elements.
Several recent reports suggest that non-coding RNAs play a role in the regulation of transcription through epigenetic modifications, [for a review see [32] ]. Repeat elements, particularly LINEs, are known to participate in the silencing of genes on the X chromosome [33] . Expression of LINEs in the vicinity of genes is instrumental for their inclusion into the Xist silencing compartment [33] . It is not yet known whether transcripts from LINE elements are associated with chromatin remodelling complexes to mediate epigenetic changes and fine-tune gene transcription, but we note that the elevated repeat elements were found in the nuclear compartment of the Mecp2 KO mouse brain cells [24] and there is emerging evidence of enrichment of LINEs in nuclear and chromatin fraction of cells [34] . A recent report using a retrotransposon capture sequencing technique (RC-seq) reveals that somatic transposition of LINE-1 (L1) in the hippocampus results in insertions, predominantly in exons and introns of protein coding genes [35] . Comparing microarray data with their RCseq data, Baillie et al. reported that intronic L1 insertions are likely to cause overexpression of such genes in the brain, suggesting a regulatory role for L1 [35] . It is not clear if the increase in retrotransposon expression in the Mecp2 KO brain leads to their active transposition even in post mitotic neurons. Random integration of transposons is suppressed in differentiated somatic cells by transcriptional [36] and post-transcriptional mechanisms [37] . It would be interesting to investigate if somatic retrotransposition is increased in the Mecp2 KO brain and whether overexpressed genes identified in Mecp2 KO mouse show novel intronic L1 insertion events.
Retrotransposons such as LINEs can be further processed into short 21-24 nucleotide double stranded siRNAs [38] or into single stranded 24-31 nucleotide long piRNAs [39, 40] . Watanabe et al. described in mouse oocytes dicer dependent double stranded endogenous siRNAs mapping exclusively to retrotransposons or expressed mRNA transcripts [38] . While the presence of endogenous siRNAs has not been demonstrated in the mouse brain, given that such short RNAs are shown to regulate the expression levels of specific genes and specific retrotransposons [38, 41] , and that dysfunctional MeCP2 may result in the overexpression of LINE-1 [24, 31] , it would be interesting to investigate the presence of endogenous siRNAs in the MeCP2 KO mouse brain.
piRNAs are germ line specific short RNAs of size 24 to 31 nucleotides generated through dicer independent processing of long single strand RNA transcripts. piRNAs interact with the PIWI proteins (MILI, MIWI and MIWI2 in mouse) [39, 40] and their function, though not fully understood, appears to relate to silencing of transposons especially LINE-1 [39, 40, 42] intracisternal A particles [39, 40] and specific genes through DNA hypermethylation [43] . In mouse testis, 17% of piRNAs bound to the MIWI protein map to repeats including LINEs, SINEs and LTRs [40] . In addition, through a unique ping-pong cycle, piRNAs are amplified from existing retrotransposon transcripts, mostly LINE-1 elements [44, 45] . This amplification cycle also results in the depletion of LINE-1 in germ line cells and is believed to deplete the levels of retrotransposon transcripts after differentiation [42] . Thus piRNAs regulate expression of LINEs and Intracisternal A particles both transcriptionally and post transcriptionally. Interestingly, piRNAs have recently been shown to regulate expression of a single imprinted gene in an imprinted locus in mouse spermatogonia via DNA methylation by piRNA targeting of a non coding RNA (pit-RNA) arising from the locus [43] . It is as yet not known if such specific targeting by piRNAs is a widespread phenomenon, nevertheless it highlights a mechanism through which piRNAs may regulate expression of specific genes.
Until recently, piRNAs and their associated proteins were presumed to be germ line specific in mouse, but a report published last year confirmed the presence of MI-WI and its associated piRNAs in the mouse hippocampus through sequencing, RIP-qPCR, northern blots, western blots and in situ hybridization studies [46] . Through bioinformatics analysis, Lee at al. identified specific piRNAs expressed in the brain and showed through piRNA inhibition studies, that one piRNA in the brain, DQ541777, may play a role in regulating the size of dendritic spines [46] . It appears plausible that in the absence of MeCP2, over expression of repeat elements, particularly LINE-1 may result in an increase in piRNA amplification from transposons. It would be interesting to investigate whether akin to germ line cells, in brain also, the increase in piRNAs result in depletion of retrotransposon transcript levels through transcriptional and post transcriptional silencing. The mechanism of transcriptional silencing by piRNAs through DNA methylation may require recruitment of repressor complexes by proteins that bind methylated DNA, including MeCP2, thus highlighting a feedback loop for MeCP2 requirement.
To investigate our hypothesis that piRNAs may be overexpressed in the Mecp2 KO mouse brain, we analysed a short RNA library made from mouse cerebellum [47] . To identify miRNAs differentially expressed in the cerebellum, Wu et al. performed short RNA sequencing of pooled 6 week old pre-symptomatic wildtype and Mecp2 KO cerebellum (n = 4 in each pool) using the SOLiD version 2 sequencer [47] . We downloaded the pooled libraries from the DDBJ database (DDBJ accession number SRP005132). ncRNAs were downloaded from NONCODE version 3 [48] and a total of 75,814 mouse piRNAs were extracted from this database. As the SOLiD reads correspond to the 5' ends of small RNAs, we directly mapped the respective reads from the pooled WT and KO libraries, using SHRiMP version 2.2.2 [49] with the default parameters, to the mouse piRNAs. After mapping we corrected tag numbers for reads multi-mapping to more than one piRNA, so that if a read mapped equally well to 2 or more individual piRNA sequences, the tag numbers were divided by the number of times it multi mapped, followed by equal assignment to all the piRNAs. For expression analysis we did not take into consideration multi mapped reads that mapped to 5 or more piRNAs and also filtered out reads that had less than 5 tags in the KO samples. The tag numbers were normalized by tags per million before comparison between wildtype and KO samples. Our very preliminary analysis of piRNAs in the cerebellum reveals 357 piRNAs in the cerebellum libraries (Supplementary Table 1 ). While 81% (287) of the individual piRNAs found in the cerebellum have a higher expression in KO, 59% (208) piRNAs show an expression change of over 1.5 fold in the KO cerebellum compared with the wildtype (Fig. 1B and supplementary Table 1 ). Overall, we found a striking 1.9 fold increase in the total piRNAs in the KO cerebellum in comparison with the wildtype cerebellum (Table 1 and Fig. 1A ) suggesting a global increase in piRNAs in the Mecp2 KO sample. We next investigated whether the 20 most abundant piRNAs identified by Lee et al. in the mouse hippocampus were represented in the mouse cerebellum [46] . We found 19 out of the 20 piRNAs reported by Lee et al. in the cerebellum libraries (Table 2) including DQ 541777 (the piRNA implicated in regulating the size of dendritic spines) and of these, 12 piRNAs (60%) revealed a fold change of over 1.5 in the KO cerebellum (Table 2) . Interestingly, DQ541777 is the 5 th most abundant piRNA in the cerebellum libraries, the two most highly abundant piRNAs in the cerebellum libraries map to rRNA loci, which were incidentally excluded in the hippocampal analysis [46] . Based on our preliminary findings, we suggest a model for Rett Syndrome where, in the absence of a functional MeCP2, the over-expressed repeat elements lead to an increase in the total piRNAs. The overrepresented piRNAs may function, not only to deplete the load of repeat transcripts in cells, but also to finetune the expression level of specific genes. Thus piR-NA mis-regulation may contribute to some of the differences in gene expression seen in the Mecp2 KO mouse brain.
While our analyses provide preliminary evidence of genome wide piRNA over-expression in the Mecp2 KO cerebellum, this data was generated from libraries without replicates. Thus additional detailed investigations are warranted to affirm the over-representation of piRNAs and gain insights into the extent of their contribution to the gene mis-regulation seen in the Rett mouse model. We did not venture into the identification of gene targets of mis-regulated piRNAs and their intersection with the known mis-regulated genes or repeats. Such data may provide insights into the mis-regulation of some genes and the biogenesis of the over-represented piRNAs. Notably, in humans and mouse, an absence of MeCP2 results in fewer dendritic spines when compared with wildtype neurons [50, 51] . While inhibition of DQ541777 was reported to cause a decrease in spine density, whether the overexpression of piRNAs, including DQ541777, can cause such morphological changes in the brain is not yet known. Further, recent reports have demonstrated that unlike mRNAs, miRNAs are stable in extracellular environments including blood serum [52, 53] . Although such analyses have not been conducted for piRNAs, if piRNAs are found to be stable in extracellular fluids, differentially expressed piRNAs may potentially represent clinical biomarkers for the diagnosis and prognosis of Rett Syndrome.
There is overwhelming complexity in unravelling the molecular pathogenesis of the phenotype seen in Rett syndrome. Although the miRNA repertoire of Mecp2 KO cerebellum has been investigated using next generation sequencing approaches, the field would benefit in re-identifying mis-regulated transcripts through deep, long and short (to identify sRNAs other than miRNAs), RNA sequencing of specific brain regions. Additionally, RC-seq conducted to identify somatic integration events would reveal whether the overexpressed genes are correlated with intronic LINE-1 insertion events. And while it has been established for the Mecp2 KO mouse model, that investigating a specific brain region is more fruitful than investigating the whole brain [26] , analysis of neuronal subtypes would be even more insightful. Until now, the isolation of neuronal subtypes from adult mouse brain using high throughput techniques such as FACS sorting was challenging, yielding few nuclei and poor quality RNA. A recently pub- lished trehalose enhanced technique for FACS sorting individual neuronal subtypes could help isolate high quality RNA from Mecp2 null neuronal subtypes for transcriptome sequencing [54] .
In conclusion, we propose that overexpression of LINE-1 may contribute to the mis-regulation of some genes in Rett syndrome, mediated through insertional events or by an increase in piRNAs (Fig. 2) . Our preliminary data suggests that piRNA expression levels may be altered globally in the absence of MeCP2. Appli- 
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Supplementary Table 1 List of piRNAs, found in the cerebellum samples in wildtype and Mecp2 KO samples with their tag numbers and normalized tags per million (Tpm) values. This list was generated after filtering out piRNAs with less than 5 tags in the Mecp2 KO sample. Top 20 piRNAs reported to be present in the hippocampus [38] are highlighted in bold. Tpm was calculated by dividing the tag numbers by the total number of reads in the library (see Table 1 
